Global Research

Welcome to our area for leading global research and researchers on post covid syndrome. Here you can find out about numerous projects that are ongoing or planned in the future. Some research projects only permit hospitalised or ventilated patients whilst others allow non hospitalised patients. For now these will be set up as links. If you have a project you wish to advertise please email Lou at

Organisations Sponsoring Ongoing Post Covid Research

The Open Medicine Foundation, USA

UK Research & Innovation (UKRI)

UK National Institute Of Health & Research (NIHR)

European Commission

(CDC) Centre for Disease Control, USA

(FDA) Food & Drug Administration, USA Government

Calls for Proposals for Research on Post Covid Syndrome


This is an ongoing mapping study (imaging) of damage to organs (heart, lungs, spleen, kidneys, liver, gall) run by Perspectum and Dr Banarjee’s team in Oxford. Many of this group participate in. So far 70% are showing at least one organ damage and around 40% two or more. Every 6 months patients are scanned, with a ECG. Reduced left ventricular ejection and mitral valve issues are commonly being reported in such patients as well as liver inflammation. There is a link to the project here

The findings are shared on their webinar series here

Alternative Global Research Projects

This is an alternative, thinking outside the box project. Long Covid is thought to be caused by a cascade of:
1. Secondary Infections of the Blood
2. Mast Cell / Platelet Activation due to serotonin dysfunction
3. Reactivation of dormant neurotrophic viruses like Epstein-Barr

This research which has been run by another team and have assembled a group of biotechs ‘thinking outside the box’ .

Nikita Alexandrov, independent researcher and Biotech Scientist/Dr Adrian Wetzel

Mr Alexandrov is a member of the group. Currently numerous patients are trialling a suggested list of vitamin compounds that have been trialled in around 50 long covid patients and found to have had some success. The work is a trial but does not require an ethics code as it is compound based. The volunteers (who have chosen to do this themselves will be reporting as a group back to the team and if successful, may call on it to be launched as a clinical trial-which they are currently looking at). The work is based on a blood disease and linked to serotonin, mast cells and the gut-brain axis.